What are the major opportunities in the Pharmacogenetic Testing market? What are the strategies for the Pharmacogenetic Testing market?

For detailed insights on the major opportunities and strategies in the Pharmacogenetic Testing market, Read More

How does the Pharmacogenetic Testing market relate to the overall economy and other similar markets?

For detailed insights on Pharmacogenetic Testing's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Pharmacogenetic Testing market growth? SWOT analysis of the Pharmacogenetic Testing market.

For detailed insights on the key dynamics influencing the Pharmacogenetic Testing market growth and SWOT analysis of the Pharmacogenetic Testing industry, Read More

Pharmacogenetic Testing Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Pharmacogenetic Testing Market Report 2026

Name: Pharmacogenetic Testing Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests), By Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications), By Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas), By Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services), By End User (Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharmacogenetic Testing Market Overview

• Pharmaco genetic Testing market size has reached to $14.33 billion in 2025

• Expected to grow to $29.55 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%

• Growth Driver: Impact Of Personalized Medicine On The Growth Of The Pharmacogenetic Testing Market

• Market Trend: Advancements In Prescription-Based Pharmacogenetic Testing

• Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Pharmacogenetic Testing Market?

Pharmacogenetic testing is a type of genetic testing that examines how an individual's genetic makeup influences their response to specific medications, helping to tailor drug treatments for better efficacy and reduced side effects. This personalized approach enhances patient care by tailoring therapies based on genetic profiles. It is widely used in fields such as oncology, psychology, and cardiology.

The main types of pharmacogenetic testing are whole genome sequencing, whole exome sequencing, array-based tests, and single gene tests. Whole genome sequencing is a comprehensive method for analyzing the entire genome of an organism. It involves sequencing all of the DNA in a single test, providing a complete picture of an individual's genetic makeup. Droug type includes prescription drugs, nutraceuticals, recreational drugs, herbal supplements, vitamins, and over-the-counter medications for different therapeutic areas such as cardiology, gastroenterology, anesthesiology, genomics, endocrinology, immunology and hypersensitivity, dermatology, gynecology, oncology, and others. These are distributed through hospital pharmacies, retail pharmacies, mail-order pharmacies, and direct-to-customer services and are used by various end users, such as healthcare providers, pharmaceutical and biotechnology companies, centers and academic institutes, and others.

Pharmacogenetic Testing Market Global Report 2026 Market Report bar graph

What Is The Pharmacogenetic Testing Market Size and Share 2026?

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $14.33 billion in 2025 to $16.58 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to advances in genomic sequencing technologies, adverse drug reaction concerns, rising chronic disease burden, declining genetic testing costs, increased clinical awareness.

What Is The Pharmacogenetic Testing Market Growth Forecast?

The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $29.55 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to growth of precision healthcare, expansion of direct-to-consumer testing, integration with electronic health records, increasing regulatory support, rising investment in genomics research. Major trends in the forecast period include rising adoption of personalized medicine, increasing use of genetic testing in drug selection, expansion of oncology and cardiology applications, growing demand for precision diagnostics, integration of pharmacogenomics in clinical practice.

Book your 30 minutes free consultation with our research experts

Global Pharmacogenetic Testing Market Segmentation

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Is The Driver Of The Pharmacogenetic Testing Market?

The increasing demand for personalized medicine is expected to propel the growth of the pharmacogenetic testing market going forward. Personalized medicine, or precision medicine, refers to a healthcare approach that tailors treatments and medical decisions to an individual’s unique genetic, biological, and lifestyle characteristics. The demand for personalized medicine is rising due to its ability to improve treatment outcomes, support early detection, and enhance cost-effectiveness in patient care. The pharmacogenetic testing market supports personalized medicine by analyzing an individual's genetic profile to predict drug responses, enabling optimized treatment selection and reducing the risk of adverse reactions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 approvals in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the pharmacogenetic testing industry.

Key Players In The Global Pharmacogenetic Testing Market

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Global Pharmacogenetic Testing Market Trends and Insights

Major companies operating in the pharmacogenetics testing market are focusing on developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to enhance medication safety, improve treatment precision, and support personalized therapeutic decision-making. Prescription-based pharmacogenetic testing refers to genetic analyses ordered by licensed healthcare providers to examine how an individual’s genetic makeup influences their response to specific medications, allowing clinicians to optimize drug selection and dosing while reducing the likelihood of adverse drug reactions. For instance, in May 2023, UCSF, a US-based healthcare organization, launched its pharmacogenomics testing service designed to improve the precision of medical treatments, providing healthcare professionals with genetic insights that help tailor drug therapies to each patient’s unique profile, strengthen drug efficacy, and minimize the risk of harmful side effects.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pharmacogenetic Testing Market?

In May 2023, HealthOme, a US-based company specializing in advanced genetic testing and personalized medicine solutions, acquired Kailos Genetics for an undisclosed amount. This acquisition strengthens HealthOme’s personalized medicine portfolio by integrating Kailos Genetics’ advanced genomic technologies and pharmacogenetic capabilities. It further enhances HealthOme’s ability to deliver comprehensive precision-testing solutions through expanded expertise in genomic analysis and individualized treatment insights. Kailos Genetics is a US-based company that provides pharmacogenetic testing services through its Inspexion platform.

Regional Insights

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmacogenetic Testing Market?

The pharmacogenetic testing market consists of revenues earned by entities by providing services such as predicting drug efficacy, guiding dosage selection, and preventing adverse drug reactions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmacogenetic testing market also includes sales of gene panels, deoxyribonucleic acid (DNA) sequencers, and home testing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmacogenetic Testing Market Report 2026?

The pharmacogenetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pharmacogenetic Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$16.58 billion
Revenue Forecast In 2035	$29.55 billion
Growth Rate	CAGR of 15.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Drug Type, Therapeutic Area, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Bio
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pharmacogenetic Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pharmacogenetic Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pharmacogenetic Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pharmacogenetic Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Personalized Medicine

4.2.2 Increasing Use Of Genetic Testing In Drug Selection

4.2.3 Expansion Of Oncology And Cardiology Applications

4.2.4 Growing Demand For Precision Diagnostics

4.2.5 Integration Of Pharmacogenomics In Clinical Practice

5. Pharmacogenetic Testing Market Analysis Of End Use Industries

5.1 Healthcare Providers

5.2 Hospitals

5.3 Diagnostic Laboratories

5.4 Pharmaceutical Companies

5.5 Academic Research Centers

6. Pharmacogenetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmacogenetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmacogenetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pharmacogenetic Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pharmacogenetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pharmacogenetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmacogenetic Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmacogenetic Testing Market Segmentation

9.1. Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

9.2. Global Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

9.3. Global Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

9.4. Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

9.5. Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

9.6. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

9.7. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

9.8. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Array-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

9.9. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Single Gene Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

10. Pharmacogenetic Testing Market Regional And Country Analysis

10.1. Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmacogenetic Testing Market

11.1. Asia-Pacific Pharmacogenetic Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmacogenetic Testing Market

12.1. China Pharmacogenetic Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmacogenetic Testing Market

13.1. India Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmacogenetic Testing Market

14.1. Japan Pharmacogenetic Testing Market Overview

14.2. Japan Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmacogenetic Testing Market

15.1. Australia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmacogenetic Testing Market

16.1. Indonesia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmacogenetic Testing Market

17.1. South Korea Pharmacogenetic Testing Market Overview

17.2. South Korea Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmacogenetic Testing Market

18.1. Taiwan Pharmacogenetic Testing Market Overview

18.2. Taiwan Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmacogenetic Testing Market

19.1. South East Asia Pharmacogenetic Testing Market Overview

19.2. South East Asia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmacogenetic Testing Market

20.1. Western Europe Pharmacogenetic Testing Market Overview

20.2. Western Europe Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmacogenetic Testing Market

21.1. UK Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmacogenetic Testing Market

22.1. Germany Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmacogenetic Testing Market

23.1. France Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmacogenetic Testing Market

24.1. Italy Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmacogenetic Testing Market

25.1. Spain Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmacogenetic Testing Market

26.1. Eastern Europe Pharmacogenetic Testing Market Overview

26.2. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmacogenetic Testing Market

27.1. Russia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmacogenetic Testing Market

28.1. North America Pharmacogenetic Testing Market Overview

28.2. North America Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmacogenetic Testing Market

29.1. USA Pharmacogenetic Testing Market Overview

29.2. USA Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmacogenetic Testing Market

30.1. Canada Pharmacogenetic Testing Market Overview

30.2. Canada Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmacogenetic Testing Market

31.1. South America Pharmacogenetic Testing Market Overview

31.2. South America Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmacogenetic Testing Market

32.1. Brazil Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmacogenetic Testing Market

33.1. Middle East Pharmacogenetic Testing Market Overview

33.2. Middle East Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmacogenetic Testing Market

34.1. Africa Pharmacogenetic Testing Market Overview

34.2. Africa Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmacogenetic Testing Market Regulatory and Investment Landscape

36. Pharmacogenetic Testing Market Competitive Landscape And Company Profiles

36.1. Pharmacogenetic Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pharmacogenetic Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pharmacogenetic Testing Market Company Profiles

36.3.1. CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Eurofins Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bio-Rad Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Pharmacogenetic Testing Market Other Major And Innovative Companies

Precision Medicine Advisors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript

38. Global Pharmacogenetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmacogenetic Testing Market

40. Pharmacogenetic Testing Market High Potential Countries, Segments and Strategies

40.1 Pharmacogenetic Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Pharmacogenetic Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Pharmacogenetic Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Pharmacogenetic Testing Market, Overview Of Key Products - Product Examples

Table 2: Global Pharmacogenetic Testing Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Pharmacogenetic Testing Market, Supply Chain Analysis

Table 4: Global Pharmacogenetic Testing Market, Major Raw Material Providers

Table 5: Global Pharmacogenetic Testing Market, Major Resource Providers

Table 6: Global Pharmacogenetic Testing Market, Major Manufacturers (Suppliers)

Table 7: Global Pharmacogenetic Testing Market, Major Distributors And Channel Partners

Table 8: Global Pharmacogenetic Testing Market, Key Technologies & Future Trends

Table 9: Global Pharmacogenetic Testing Market, Major Trends

Table 10: Global Pharmacogenetic Testing Market, Major End Users

Table 11: Global Pharmacogenetic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Pharmacogenetic Testing Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Pharmacogenetic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Pharmacogenetic Testing Market - TAM, US$ Billion, 2025

Table 15: Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Array-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Single Gene Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Pharmacogenetic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Pharmacogenetic Testing Market - Company Scoring Matrix

Table 100: CVS Health Corporation Financial Performance

Table 101: Thermo Fisher Scientific Inc. Financial Performance

Table 102: Quest Diagnostics Incorporated Financial Performance

Table 103: Eurofins Scientific Inc. Financial Performance

Table 104: Bio-Rad Laboratories Financial Performance

Table 105: Global Pharmacogenetic Testing Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Pharmacogenetic Testing Market, Competitive Dashboard

Table 107: Global Pharmacogenetic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Pharmacogenetic Testing Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 109: Global, Pharmacogenetic Testing Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 110: Global, Pharmacogenetic Testing Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030

List Of Figures

Figure 1: Global Pharmacogenetic Testing Market, Overview Of Key Products - Product Examples

Figure 2: Global Pharmacogenetic Testing Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Pharmacogenetic Testing Market, Supply Chain Analysis

Figure 4: Global Pharmacogenetic Testing Market, Major Raw Material Providers

Figure 5: Global Pharmacogenetic Testing Market, Major Resource Providers

Figure 6: Global Pharmacogenetic Testing Market, Major Manufacturers (Suppliers)

Figure 7: Global Pharmacogenetic Testing Market, Major Distributors And Channel Partners

Figure 8: Global Pharmacogenetic Testing Market, Key Technologies & Future Trends

Figure 9: Global Pharmacogenetic Testing Market, Major Trends

Figure 10: Global Pharmacogenetic Testing Market, Major End Users

Figure 11: Global Pharmacogenetic Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Pharmacogenetic Testing Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Pharmacogenetic Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Pharmacogenetic Testing Market - TAM, US$ Billion, 2025

Figure 15: Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Array-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Pharmacogenetic Testing Market, Sub-Segmentation Of Single Gene Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Pharmacogenetic Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Pharmacogenetic Testing Market - Company Scoring Matrix

Figure 100: CVS Health Corporation Financial Performance

Figure 101: Thermo Fisher Scientific Inc. Financial Performance

Figure 102: Quest Diagnostics Incorporated Financial Performance

Figure 103: Eurofins Scientific Inc. Financial Performance

Figure 104: Bio-Rad Laboratories Financial Performance

Figure 105: Global Pharmacogenetic Testing Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Pharmacogenetic Testing Market, Competitive Dashboard

Figure 107: Global Pharmacogenetic Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Pharmacogenetic Testing Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 109: Global, Pharmacogenetic Testing Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 110: Global, Pharmacogenetic Testing Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Advance Directives Market Report 2026 - Global Outlook – By Component (Software, Services), By Demographics (Elderly Population (More Than 65 years), Middle Aged (40 To 64 years), Young Adults (18 To 39 years)), By End U...

In-App Purchase Market Report 2026 - Global Outlook – By Type (Consumable, Non-Consumable, Subscription), By Operating System (Android, iOS, Other Operating Systems), By App Category (Gaming, Entertainment And Music, Hea...

Population Health Management Market Report 2026 - Global Outlook – By Component (Software, Service), By Mode Of Delivery (On Premise, Cloud-Based), By End-User (Providers, Payers, Other End-Users) - Market Size, Trends, ...

Passenger Car Rental Market Report 2026 - Global Outlook – By Vehicle Type (Luxury Cars, Executive Cars, Economy Cars, Sports Utility Vehicle(SUV), Multi Utility Vehicle(MUV)), By Rental Duration (Long-Term, Short-Term),...

Dental Veneers Market Report 2026 - Global Outlook – By Product (Porcelain Veneers, Composite Veneers, Other Products), By Application (Cosmetic, Medical), By End Users (Hospitals, Dental Clinics, Other End Users) – Mark...

Vegan Ice Cream Market Report 2026 - Global Outlook – By Source (Coconut Milk, Almond Milk, Cashew Milk, Soy Milk), By Product (Impulse, Artisanal, Take Home), By Form (Singles, Blends), By Flavor (Vanilla, Chocolate, Bu...

HPV Associated Disorders Market Report 2026 - Global Outlook – By Indication (Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications...

Frequently Asked Questions

How big is the Pharmacogenetic Testing Market?

The Pharmacogenetic Testing market was valued at $14.33 billion in 2025, increased to $16.58 billion in 2026, and is projected to reach $29.55 billion by 2030.

What is the Pharmacogenetic Testing market growth?

The global Pharmacogenetic Testing market is expected to grow at a CAGR of 15.5% from 2026 to 2035 to reach $29.55 billion by 2035.

Who are the key players in Pharmacogenetic Testing market?

Some Key Players in the Pharmacogenetic Testing market Include, CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, F

Major trend in this market includes: Advancements In Prescription-Based Pharmacogenetic Testing. For further insights on this market. request a sample here

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pa

Book your 30 minutes free consultation with our research experts

Contact Us